RNA and genetic medicines technology has undergone transformative evolution in recent years with major advancements in mRNA, RNA, DNA, and viral-based therapies. The RNA and Genetic Medicines stream delves into the technical challenges associated with bringing these therapies from early-stage development to commercial success, from CMC best practice to intricate analytics and characterization methodologies. Featuring ongoing advancements in scalable and cost-effective manufacturing, we aim to explore the latest breakthroughs, address challenges, and pave the way for the continued success of RNA, mRNA, and viral vector-based therapeutics and vaccines for both personalized and large indications. 

Conferences Include: